South America Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire localization, Radioisotope localization, Magnetic Localization, Others), By Usage (Tumor Identification, Sentinel Lymph Node Identification) and By Country (Brazil, Argentina, Rest of South America) Forecasts, 2026-2034

Market Overview

The south america breast lesion localization methods market size was valued at USD 58 million in 2025 and is projected to grow from USD 64.09 million in 2026 to  USD 142.46 million by 2034 at a CAGR of 10.5% during the forecast period 2026-2034.

Rapid urbanization in these countries has led to a significant migration of people towards urban areas. This has created a need for government and private entities to expand their healthcare infrastructure to accommodate the growing population. Our research findings indicate that government hospitals in these regions lack technology and resources, which has prompted private hospitals to make substantial investments in acquiring advanced equipment to attract more patients and take advantage of the gap in public healthcare services.

The acceptance and usage of breast lesion localization methods, including MRI, ultrasound, and mammography, is contingent upon the healthcare infrastructure of the specific healthcare systems.

Segmental Analysis

The South American breast lesion localization methods market is segmented into type and usage.

By type, it is further segmented into wire localization, radioisotope localization, magnetic localization, and others.

Wire localization dominated the market and is expected to register a CAGR of 15.0% over the forecast period. Wire localization is used to designate the precise location of the lesion, which assists the surgeon in detecting and removing breast lesions if an X-ray reveals multiple lesions. The technique is favored for removing lesions or tumors that are difficult to locate and cannot be felt. In addition, it can be used to remove the smallest possible area, which would be difficult for a surgeon to do without causing obvious harm to the surrounding tissue. The procedure is painless, but some women may experience pressure or vertigo.

Request Customizationto receive a tailored report.

Based on usage, it is further segmented into tumor identification and sentinel lymph node identification.

Tumor identification dominated the market and is expected to register a CAGR of 14.2% over the forecast period. A physical examination, or breast imaging, which primarily consists of mammography and a biopsy, is performed to identify tumors. It is commonly performed on women with breast cancer. Mammography utilizes X-rays to image the breast region containing a tumor. In addition, various imaging technologies, such as MRI and ultrasound, are also utilized. Ultrasound is primarily recommended for women under the age of 30.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The South American market for breast lesion localization methods is experiencing growth due to the increasing prevalence of breast cancer. Brazil and Argentina are the leading countries in terms of market share. The market is driven by advancements in medical technology, rising awareness about early detection, and government initiatives to improve healthcare infrastructure. In Latin America, breast cancer is the most prevalent cancer among women. Each year, over 115,000 women are diagnosed with cancer, and over 37,000 women diagnosed with cancer pass away. The prevalence and mortality rate is anticipated to double over the next two decades. In the region, aging is one of the most prevalent causes of diagnosis.

The market has witnessed a significant increase in the survival rate over the past five years due to advancements in early diagnosis technology and improved treatment options. The survival percentage has increased from 70% five years ago to 80% today.

Despite an improved survival rate, several Latin American nations lack the necessary healthcare infrastructure to accommodate the rising incidence of breast cancer. Due to late cancer diagnosis, poor economic status of patients, lack of insurance coverage, and a dearth of qualified oncologists in the region, the survival rate in most countries ranges between 60 and 70 percent. For example, in countries such as Peru, Colombia, and Mexico, approximately fifty percent of breast cancer cases are diagnosed at an advanced stage. Late diagnosis hurts the survival rate and significantly raises per-case health expenditures.

List of Key and Emerging Players in South America Breast Lesion Localization Methods Market